For health care professionals in EUROPE excepted those practicing in France as the following pages are intended to all International health care professionals and are not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Other health care professionals should select their country in the top right corner of the website.
Please note that the following pages are exclusively reserved for health care professionals in countries with applicable health authority product registrations. To the extent this site contains information, reference guides and databases intended for use by licensed medical professionals, such materials are not intended to offer professional medical advice. Prior to use, please consult device labeling for prescriptive information and operating instructions.
This Website is protected by the laws on copyright and by the relevant international conventions. It is strictly forbidden to make copies, whether partial or total and on whichever media without prior approval.
Despite decades of successful CRT therapy, there is still a recognised non-responder rate of 15-45%.1
Current and historical methods for achieving CRT response vary:
None of these methods have proven to be solely efficacious 100% of the time. Instead of relying on one method alone, a more systematic approach is needed in order to improve CRT response. Apart from patient selection, there are three aspects over which physicians have control and which can change the level of patient benefit:
SmartCRT, Boston Scientific’s approach to personalised CRT therapy, provides physicians with smart solutions to choose where, when and how to pace for optimal results.
The following products feature SmartCRT: